Alnylam Pharmaceuticals
ALNY
#453
Rank
ยฃ38.65 B
Marketcap
ยฃ292.60
Share price
-5.18%
Change (1 day)
46.98%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company